Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Download White Paper
IT in
Healthcare,
Patient
Monitoring &
Telemedicine

Download White Paper

 
Matching geography
Reports matching your search in:
 
 
Download SlideShare
20
Hot
Stats on
Healthcare
IT

Download SlideShare

 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Therapeutic Area market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
Cardiac Fibrosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Cardiac Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis. Cardiac Fibrosis - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Male Sexual Dysfunction – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Male Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Sexual Dysfunction. Male Sexual Dysfunction ...  |  read more...
$2,000.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - US Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
... this market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ...  |  read more...
$4,450.00
Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...  |  read more...
$2,000.00
Essential Tremor – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... for Essential Tremor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Tremor. Essential Tremor - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Cancer Pain Global Clinical Trials Review, H1, 2013
4/30/2013 | published by: GlobalData
... information and data relating to the clinical trials on Cancer Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
$2,500.00
Xerosis (Dry Skin) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) ...  |  read more...
$2,000.00
Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also ...  |  read more...
$2,000.00
Influenza A And B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... provides information on the therapeutic development for Influenza A And B Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ...  |  read more...
$2,000.00
Arrhythmias – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arrhythmias. Arrhythmias - Pipeline Review, Half Year is built using data and ...  |  read more...
$2,000.00
Soft Tissue Sarcoma – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... therapeutic development for Soft Tissue Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma. Soft Tissue Sarcoma ...  |  read more...
$2,000.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - South America Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
... diagnostics market remains of high interest due to advancements in assay sensitivity both on laboratory and point-of-care platforms. GlobalData expects these advancements to have an impact on other diagnostic tests such as creatine kinase-MB isoenzyme ...  |  read more...
$4,450.00
Acute Spinal Cord Injury – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
... on the therapeutic development for Acute Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Spinal Cord ...  |  read more...
$2,000.00
Global Eye Care Surgical Market  2012-2016
4/30/2013 | published by: Infiniti Research Limited
... this market growth is the increase in prevalence of eye disorders. The Global Eye Care Surgical market has also been witnessing the trend of an increase in mergers and acquisitions. However, the lack of awareness ...  |  read more...
$2,000.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - Current and Future Players
4/30/2013 | published by: GlobalData
... of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency ...  |  read more...
$3,500.00
Mental Health & Substance Abuse Services
4/29/2013 | published by: First Research, Inc.
... include CRC Health and The Betty Ford Center in the US, the Centre for Addiction and Mental Health in Canada, and the Crossroads Centre in Antigua. Globally, resources for mental health services vary by region. ...  |  read more...
$129.00
2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
4/29/2013 | published by: Venture Planning Group
... landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. Rationale The growing economic pressures on ...  |  read more...
$4,500.00
Global Deep Brain Stimulator Market 2012-2016
4/26/2013 | published by: Infiniti Research Limited
... this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. However, ...  |  read more...
$2,000.00
Mental Health & Substance Abuse Centers in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within ...  |  read more...
$1,020.00
Psychiatric Hospitals in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural ...  |  read more...
$1,020.00
Optometrists in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...  |  read more...
$1,020.00
Chiropractors in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...  |  read more...
$1,020.00
Family Planning & Abortion Clinics in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the ...  |  read more...
$1,020.00
Mental Health & Substance Abuse Clinics in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
... 'the difficulty, or otherwise, of the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within ...  |  read more...
$1,020.00
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
... developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 196 drugs. Androgen Receptor Signaling Pathway In Oncology Drug Pipeline ...  |  read more...
$5,621.25
< prev 1  2  3  4  5  6  7  8  9  10  next >